Coronavirus (COVID-19) resources

Celsior solution versus University of Wisconsin solution in liver preservation for transplantation

To assess the beneficial and harmful effects of Celsior solution versus University of Wisconsin solution in liver preservation for transplantation.

This is a protocol.

You may also be interested in:

Conversion of calcineurin inhibitor treatment to target of rapamycin inhibitor treatment versus continuation of calcineurin inhibitor treatment for liver transplant recipients
Methods to decrease blood loss and transfusion requirements for liver transplantation
Mycophenolate mofetil for liver-transplanted patients
Pharmacological interventions to decrease ischaemia reperfusion injury in liver transplantation
Piggy-back method versus standard method of liver transplantation

Health topics:

Gastroenterology & hepatology > Liver disorders > Transplantation

Published:

20 January 2010

Authors:

Su H, Guo TK, Ma YT, Hao XY, Li Y, Jiang L, Liu YL

Primary Review Group:

Hepato-Biliary Group

See the full Review on

the Cochrane Library

Print
PDF
Citation
Su H, Guo TK, Ma YT, Hao XY, Li Y, Jiang L, Liu YL. Celsior solution versus University of Wisconsin solution in liver preservation for transplantation. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD008301. DOI: 10.1002/14651858.CD008301

Don't show again

Close

You can help make health evidence easier to understand! No experience or expertise needed, just 30 minutes to volunteer for a study where you will read 2 summaries and answer questions. If interested, click here to provide your email for more information - it will not be used for anything else.